Kolumne, ORE

Original-Research: LION E-Mobility AG - von NuWays AG Einstufung von NuWays AG zu LION E-Mobility AG Unternehmen: LION E-Mobility AG ISIN: CH0560888270 Anlass der Studie: Update Empfehlung: BUY seit: 22.01.2024 Kursziel: 10.50 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr A new CEO to kick off the year Topic: LION announced to have a singed a highly qualified successor for the current CEO, which is leaving at the end of January.

22.01.2024 - 09:01:31

Original-Research: LION E-Mobility AG (von NuWays AG): BUY


Original-Research: LION E-Mobility AG - von NuWays AG

Einstufung von NuWays AG zu LION E-Mobility AG

Unternehmen: LION E-Mobility AG
ISIN: CH0560888270

Anlass der Studie: Update
Empfehlung: BUY
seit: 22.01.2024
Kursziel: 10.50
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Christian Sandherr

A new CEO to kick off the year
 
Topic: LION announced to have a singed a highly qualified successor for the
current CEO, which is leaving at the end of January. Following LION's major
transformation last year, the company looks poised for strong growth.
 
At the end of November, LION announced the departure of its CEO Winfried
Buss end of January due to personal reasons. The company has already been
able to find a successor, namely Dr. Joachim Damasky. Dr. Damasky has
recently worked as Senior Advisor to BMW and ran the German Automotive
Association. Until 2015, he was part of Webasto's Management Board. This
bolsters well with hire of Dr. Urlich Eichhorn, former CTO of Volkswagen,
as Chairman of its newly established Global Technical Advisory Committee at
the beginning of November. Both hires, alongside an increased salesforce
should allow for a continuation of the positive trends witnessed in Q4.
 
Mind you, during the Q3 earnings call in December, management highlighted EUR
25m of sales (vs. 9M of EUR 29m) from battery packs out of its own production
in Q4 alone. With that, LION produced roughly 4.5k battery packs during
FY23, significantly below the factory's annual capacity of 45k. Over the
next few years, we expect the utilization to gradually increase, partially
carried by the introduction of its gen 2 battery packs during the second
half of this year.
 
Thanks to the partnership with SVOLT, the company will produce higher
energy density (20% more vs currently used cells) NMC and LFP battery
packs. Especially the latter is set to turn into a notable tailwind as it
should allow LION to fully break into the thriving energy storage market,
which prefers LFP over NMC cells. Energy storage customers already account
for roughly 50% of sales.
 
Coupled with customer wins in the mobility segment, the company looks set
to strongly grow sales in the short- to mid-term (33% 2022-25e CAGR).
During the same time, the EBITDA margin is seen to significantly increase
to 4.6% by 2025e as the plant's operating leverage should kick in.
 
Valuation remains attractive. While LION has gone through a full
transformation during 2023, the company should now be ready to reap the
rewards of the hard work. Yet, this is still under-appreciated by the share
price, which implies a valuation of only 0.6x/0.4x EV/sales FY2023/24e.
LION remains a BUY with an unchanged EUR 10.50 PT based on DCF.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28719.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...